# Personalized Therapy in Non-small Cell Lung Cancer

> **NCT01781988** · PHASE2 · COMPLETED · sponsor: **Guangzhou Medical University** · enrollment: 128 (actual)

## Conditions studied

- Lung Cancer
- Carboplatin Adverse Reaction

## Interventions

- **DRUG:** carboplatin, gemcitabine , pametrexed

## Key facts

- **NCT ID:** NCT01781988
- **Lead sponsor:** Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2014-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781988, "Personalized Therapy in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01781988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*